| Announce Date | 10/30/2025 |
| EPS Normalized Actual | $1.71 (Beat by $0.11) |
| EPS GAAP Actual | $1.71 (Beat by $0.11) |
| Revenue Actual | $3.14B |
| Revenue Surprise | Beat by $3140M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $1.82 |
| EPS GAAP Estimate | $1.82 |
| Revenue Estimate | $8.6645B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2029 | 10.6 | 15.94 | 10.25065 | 10.99329 | 1 |
| Dec 2029 | 10.75 | 15.72 | 10.47059 | 10.99875 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | 1.49 | -0.15214 | 3.14B | 3.5% | 707.34M |
| FQ3 2025 (Sep 2025) | 1.43 | -0.19177 | 2.482B | -22.2% | 66.6M |
| FQ2 2025 (Jun 2025) | 1.49 | 1.49 | 3.262B | 11.19% | 3262M |
| FQ1 2025 (Mar 2025) | 1.39 | 1.39 | 3.229B | 15.42% | 3229M |
| FQ4 2024 (Dec 2024) | 1.22 | 1.22 | 3.03B | 12.01% | 3030M |
| FQ3 2024 (Sep 2024) | 1.14 | 1.14 | 3.033B | 19.91% | 3033M |
| FQ2 2024 (Jun 2024) | 1.1 | 1.1 | 2.897B | 19.36% | 2897M |
| FQ1 2024 (Mar 2024) | 1.34 | 1.34 | 2.731B | 9.48% | 2731M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
1.82
Consensus Revenue Estimates
8.6645B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 2.35 | -- | 2.35 | 2.35 | 5 |
| FQ3 2027 (Sep 2027) | 2.33 | -- | 2.33 | 2.33 | 5 |
| FQ2 2027 (Jun 2027) | 2.22 | -- | 2.22 | 2.22 | 5 |
| FQ1 2027 (Mar 2027) | 2.14 | -- | 2.14 | 2.14 | 5 |
| FQ4 2026 (Oct 2026) | 1.865 | 20.11 | 1.79893 | 1.90702 | 4 |
| FQ3 2026 (Jul 2026) | 1.835 | 22.07 | 1.76999 | 1.87634 | 4 |
| FQ2 2026 (Jun 2026) | 1.83 | 18.58 | 1.73822 | 2.06623 | 11 |
| FQ1 2026 (Mar 2026) | 1.82 | 23.63 | 1.72872 | 2.05494 | 6 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 2.94B | -- | 2.94B | 2.94B | 7 |
| FQ3 2027 (Sep 2027) | 2.93B | -- | 2.93B | 2.93B | 4 |
| FQ2 2027 (Jun 2027) | 2.84B | -- | 2.84B | 2.84B | 4 |
| FQ1 2027 (Mar 2027) | 2.78B | -- | 2.78B | 2.78B | 7 |
| FQ4 2026 (Oct 2026) | 2.64B | -19.12 | 2.56B | 2.68B | 4 |
| FQ3 2026 (Jul 2026) | 2.6B | 4.5 | 2.53B | 2.64B | 6 |
| FQ2 2026 (Jun 2026) | 9.33B | 65.04 | 8.97B | 10.26B | 5 |
| FQ1 2026 (Mar 2026) | 8.66B | 62.73 | 8.33B | 9.52B | 5 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
6
EPS # of Misses
2
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | 1.64214 | 1.49 | -0.15214 | -10.21% |
| FQ3 2025 (Sep 2025) | 1.62177 | 1.43 | -0.19177 | -13.41% |
| FQ2 2025 (Jun 2025) | 1.49 | 1.49 | 100% | |
| FQ1 2025 (Mar 2025) | 1.39 | 1.39 | 100% | |
| FQ4 2024 (Dec 2024) | 1.22 | 1.22 | 100% | |
| FQ3 2024 (Sep 2024) | 1.14 | 1.14 | 100% | |
| FQ2 2024 (Jun 2024) | 1.1 | 1.1 | 100% | |
| FQ1 2024 (Mar 2024) | 1.34 | 1.34 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | $2.43B | $3.14B | $707.34M | 22.53% |
| FQ3 2025 (Sep 2025) | $2.42B | $2.48B | $66.6M | 2.68% |
| FQ2 2025 (Jun 2025) | $0B | $3.26B | $3262M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $3.23B | $3229M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $3.03B | $3030M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $3.03B | $3033M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $2.9B | $2897M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $2.73B | $2731M | 100% |